Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar clstanely7878 (< 20) Submitted: 12/5/2012 8:30:39 AM : Outperform Start Price: $8.65 ARNA Score: -93.47

Yes

Featured Broker Partners


Advertisement